AMGN · ARWR 10-KNov 25 '25
“On September 28, 2016, Amgen and the Company entered into two collaboration and license agreements and a common stock purchase agreement.”
NVS · ARWR 10-KNov 25 '25
“On August 29, 2025, Novartis and the Company entered into a global licensing and collaboration agreement.”
AMGN · GENB S-1/AFeb 23 '26
“In addition, the Generate Platform’s modular capabilities underpin the confidential programs being developed in collaboration with Amgen Inc. ("Amgen") and Novartis Pharma AG ("Novartis").”
NVS · GENB S-1/AFeb 23 '26
“In addition, the Generate Platform’s modular capabilities underpin the confidential programs being developed in collaboration with Amgen Inc. ("Amgen") and Novartis Pharma AG ("Novartis").”
AMGN · TCRX 10-KMar 4 '26
“On May 8, 2023, the Company entered into a Collaboration Agreement with Amgen Inc. (the Amgen Agreement) to identify antigens recognized by T cells in patients with Crohn's disease in accordance with a research plan.”
NVS · TCRX 10-KMar 4 '26
“To date, our revenues have primarily consisted of consideration related to the Novartis Agreement and the Amgen Agreement, which we are accounting for under ASC 606.”